Von Willebrand gene tracking by single-tube automated fluorescent analysis of four short tandem repeat polymorphisms

Francisco Vidal; Antoni Julià; Carme Altisent; Lluís Puig; Dominique Gallardo

doi:10.1160/TH04-10-0699

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2005; 93(05): 976-981
DOI: 10.1160/TH04-10-0699

New Technologies and Diagnostic Tools

Schattauer GmbH

Von Willebrand gene tracking by single-tube automated fluorescent analysis of four short tandem repeat polymorphisms

Authors

Francisco Vidal

¹Unitat de Diagnòstic i Teràpia Molecular, Centre de Transfusió i Banc de Teixits
Antoni Julià

²Unitat de Reumatologia, Hospital General i Universitari Vall d’Hebron
Carme Altisent

³Unitat d'Hemofília, Hospital General i Universitari Vall d'Hebron, Barcelona, Spain
Lluís Puig

³Unitat d'Hemofília, Hospital General i Universitari Vall d'Hebron, Barcelona, Spain
Dominique Gallardo

¹Unitat de Diagnòstic i Teràpia Molecular, Centre de Transfusió i Banc de Teixits

Abstract

Summary

Molecular diagnosis of von Willebrand disease (VWD) has been hampered by the large size and complex genomic characteristics of the gene involved. For this reason, indirect methods using in-tragenic polymorphic markers described along the von Wille-brand factor (VWF) gene are valuable tools for gene monitoring and linkage analysis. Several studies have demonstrated the four commonly utilized short tandem repeats (STRs), three located in intron 40 and one in the promoter region of the VWF gene, to be highly informative for this task. Our objective was to develop a rapid, automated method to simultaneously analyze these four STRs for VWF gene tracking. Amplification of the four loci is achieved in a single multiplex fluorescent PCR which is then analyzed in the same run by capillary electrophoresis. Data processing with Gene Scan and Genotyper software has simplified management and tabulation of the resulting haplotypes. Analysis of the VWF gene in DNA from 102 individuals (204 chromosomes) revealed that the three STRs within intron 40 showed significant linkage disequilibrium against each other but not against the VWP locus. Moreover, the combination of the four markers offers a high heterozygosity rate (>99%) that improves tracing VWF gene inheritance. In conclusion, the automated fluorescent capillary electrophoresis method presented here is an extremely rapid, simple and highly informative technique for association studies between VWD and the VWF gene in addition to genetic counseling and prenatal diagnosis by precise linkage analysis in VWD-affected families.

Keywords

Short tandem repeats - VNTR - von Willebrand disease - von Wille-brand factor - molecular diagnosis

Full Text

References

References
1 Orstavik KH, Magnus P, Reisner H. et al. Factor VIII and factor IX in a twin population. Evidence for a major effect of ABO locus on factor VIII level. Am J Hum Genet 1985; 37: 89-101.
2 Gill JC, Endres-Brooks J, Bauer PJ. et al. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 1987; 69: 1691-5.
3 Castaman G, Federici AB, Rodeghiero F. et al. von Willebrand's disease in the year 2003towards the complete identification of gene defects for correct diagnosis and treatment. Haematologica 2003; 88: 94-108.
4 Urquhart A, Kimpton CP, Downes TJ. et al. Variation in short tandem repeat sequences--a survey of twelvemicrosatellite loci for use as forensic identification markers. Int J Legal Med 1994; 107: 13-20.
5 Ruitberg CM, Reeder DJ, Butler JM. STRBase: a short tandem repeat DNAdatabase for the human identity testing community. Nucleic Acids Res 2001; 29: 320-2.
6 Huckenbeck W, Demir K, Scheil HG. et al. German data on the HUMVWA31 locus. Anthropol Anz 1996; 54: 1-6.
7 Moretti TR, Baumstark AL, Defenbaugh DA. et al. Validation of short tandem repeats (STRs) for forensic usage: performance testing of fluorescent multiplex STR systems and analysis of authentic and simulated forensic samples. J Forensic Sci 2001; 46: 647-60.
8 Pena SD, de Souza KT, de Andrade M. et al. Allelic associations of two polymorphic microsatellites in intron 40 of the human von Willebrand factor gene. Proc Natl Acad Sci U SA 1994; 91: 723-7.
9 Ni X, Guo J, Xia J. et al. Prenatal determination of a variable number of tandem repeats in intron 40 of the von Willebrand factor gene from maternal peripheral blood using the polymerase chain reaction. Hum Hered 2000; 50: 201-4.
10 Mazzini J, Hackel C. Annichino-Bizzacchi JM.Allelic frequencies of three VNTRs in intron 40 of the human von Willebrand factor gene in types 1, 2, and 3 von Willebrand disease patients and controls of a Brazilian population. Thromb Res 2000; 100: 489-94.
11 Ploos van Amstel HK, Reitsma PH. Tetranucleotide repeat polymorphism in the vWF gene. Nucleic Acids Res 1990; 18: 4957.
12 Casaña P, Martinez F, Aznar JA. et al. Practical application of three polymorphic microsatellites in intron 40 of the human von Willebrand factor gene. Haemostasis 1995; 25: 264-71.
13 Haddad AP, Sparrow RL. Two novel alleles of the ATCT variable number tandem repeat locus VWF.VNTR I in intron 40 of the von Willebrand factor gene. Br J Haematol 1997; 96: 298-300.
14 Haddad AP, Sparrow RL. The short tandem repeat locus VWF2 in Intron 40 of the von Willebrand factor gene consists of two polymorphic sub-loci. Forensic Sci Int 2001; 119: 299-304.
15 Casaña P, Martínez F, Haya S. et al. Identification of a new candidate mutation, G1629R, in a family with type 2A von Willebrand disease. Am J Hematol 1999; 60: 309-10.
16 Habart D, Vorlova Z. Simultaneous and semi-automated evaluation of three variable tandemrepeatswithin von Willebrand factor gene by capillary electrophoresis with multicolour fluorescent detection. Acta Haematol 2003; 110: 41-2.
17 Peake IR, Bowen D, Bignell P. et al. Family studies and prenatal diagnosis in severe von Willebrand disease by polymerase chain reaction amplification of a variable number tandem repeat region of the von Willebrand factor gene. Blood 1990; 76: 555-61.
18 Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCRSSP) in 2 hours: an alternative to serological DRtyping in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992; 39: 225-35.
19 Mancuso DJ, Tuley EA, Westfield LA. et al. Structure of the gene for human von Willebrand factor. J Biol Chem 1989; 264: 19514-27.
20 Zhang ZP, Deng LP, Blomback M. et al. Dinucleotide repeat polymorphism in the promoter region of the human von Willebrand factor gene (vWF gene). Hum Mol Genet 1992; 1: 780.
21 Ott J. Strategies for characterizing highly polymorphic markers in human gene mapping. Am J Hum Genet 1992; 51: 283-90.
22 Guo SW, Thompson EA. Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 1992; 48: 361-72.
23 Schneider S, Roessli D, Excoffier L. Arlequin: A software for population genetics data analysis. In. 2.000 ed. Geneva: Genetics and Biometry Lab, Dept of Anthropology, University of Geneva. 2000
24 Cumming AM, Armstrong JG, Pendry K. et al. Polymerase chain reaction amplification of two polymorphic simple repeat sequences within the von Willebrand factor gene: application to family studies in von Willebrand disease. Hum Genet 1992; 89: 194-8.
25 Kimpton C, Walton A, Gill P. Afurther tetranucleotide repeat polymorphism in the vWF gene. Hum Mol Genet 1992; 1: 287.
26 Deforce DL, Millecamps RE, Van Hoofstat D. et al. Comparison of slab gel electrophoresis and capillary electrophoresis for the detection of the fluorescently labeled polymerase chain reaction products of short tandem repeat fragments. J Chromatogr A 1998; 806: 149-55.
27 Zhang Z, Lindstedt M, Blomback M. et al. Effects of the mutant von Willebrand factor gene in von Willebrand disease. Hum Genet 1995; 96: 388-94.
28 Castaman G, Eikenboom JC, Bertina RM. et al. Inconsistency of association between type 1 von Willebrand disease phenotype and genotype in families identified in an epidemiological investigation. Thromb Haemost 1999; 82: 1065-70.
29 Wahlberg TB, Blomback M, Magnusson D. Influence of sex, blood group, secretor character, smoking habits, acetylsalicylic acid, oral contraceptives, fasting and general health state on blood coagulation variables in randomly selected young adults. Haemostasis 1984; 14: 312-9.
30 Abildgaard CF, Suzuki Z, Harrison J. et al. Serial studies in von Willebrand's disease: variability versus “variants“. Blood 1980; 56: 712-6.
31 Blombäck M, Eneroth P, Andersson O. et al. On laboratory problems in diagnosing mild von Willebrand's disease. Am J Hematol 1992; 40: 117-20.
32 Casaña P, Martinez F, Haya S. et al. Significant linkage and non-linkage of type 1 von Willebrand disease to the von Willebrand factor gene. Br J Haematol 2001; 115: 692-700.
33 Eikenboom JC, Gomez-Garcia EB, Van Marion V. et al. Co-segregation of Von Willebrands disease type 1 phenotype and Von Willebrand factor gene haplotypes: first results from the multicenter study molecular and clinical markers for the diagnosis and management of type 1 Von Willebrands disease. J Thromb Haemost 2003; (Suppl. 01) Supplement 1-OC074.
34 Hauge XY. Litt M.Astudy of the origin of 'shadow bands' seen when typing dinucleotide repeat polymorphisms by the PCR. Hum Mol Genet 1993; 2: 411-5.
35 Clark JM. Novel non-templated nucleotide addition reactions catalyzed by procaryotic and eucaryotic DNA polymerases. Nucleic Acids Res 1988; 16: 9677-86.